Delisting

As Waldencast deregisters from the SEC and retreats to the OTC markets, the move exposes the harsh reality of indie beauty brands struggling in the public eye.

A recent Nasdaq deficiency notice for Singapore's CytoMed Therapeutics highlights the intense market pressures facing pre-revenue biotechs today.

With CFIUS clearance secured, Clear Channel Outdoor's $6.2B acquisition by Mubadala Capital signals a new era for digital out-of-home advertising.

The Chinese commercial EV maker is battling a collapsed stock price and dwindling cash, forcing a drastic ADS ratio change to maintain its US listing.

A Nasdaq deficiency notice puts ATA Creativity Global on the clock. Can the Chinese edtech firm survive its radical restructuring and avoid delisting?

Invesque's 10-cent take-private deal reveals how private credit titans are quietly absorbing distressed public real estate amid shifting capital markets.

S-Bank has cleared the 90% threshold to acquire Oma Savings Bank, creating a new banking powerhouse and signaling the end of an era for regional retail banking.

Despite booming streaming revenues, the MUSQ ETF is liquidating. We explore the brutal economics of thematic funds and what investors should do next.

Dillard's is swapping Wall Street for Dallas, marking a major victory for the Texas Stock Exchange and signaling a broader flight from Delaware.

A late SEC filing and a prior 'going concern' warning reveal deep financial turmoil at the specialty coffee innovator, raising questions about its future.

Granted a 180-day Nasdaq extension, AI infrastructure firm Alpha Compute must now prove its high-tech vision is more than a penny stock reality.

As Nasdaq threatens delisting, Hub Group's $870M meltdown reveals more than accounting errors—it's a stark lesson in corporate governance.

loanDepot touts major operational growth, yet its stock faces delisting from the NYSE. A deep dive into the company's fight for survival.

Vertical farming pioneer Agroz Inc. faces expulsion from Nasdaq, a crisis that exposes the harsh financial realities behind the promising agritech revolution.

COSCIENS Biopharma boasts a dramatic financial turnaround, but its strategic move to exit SEC oversight shifts the risk-reward calculus for investors.

Shareholders have approved Fairfax Financial's buyout of Andrew Peller Ltd., ending its public chapter. This isn't just a deal; it's a strategic uncorking.

The iconic Canadian jeweler is delisting from the NYSE American. We dig into the financial pressures and strategic calculus behind this pivotal move.

Hashdex shutters its Bitcoin ETF (DEFI) amidst fierce competition from giants. This closure reveals the harsh realities of survival in the crowded crypto space.

Gaming giant Flutter Entertainment has abandoned the London Stock Exchange for New York. It's more than a listing change; it's a strategic realignment.

Allied Universal's major Canadian acquisition of SSC signals a market consolidation, while a management buy-out creates a new specialized cyber player.